Drug Trial Radar · NCT04732416
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
Last checked: Nov 19, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
17
Actual
Start
May 5, 2022
Primary completion
Jun 16, 2026
Study completion May 2027
Sponsor
- Lead sponsor
- Hanmi Pharmaceutical Company LimitedIndustry
- Sponsor type
- Industry
- First posted
- Feb 1, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15136 when used as add-on therapy in subjects with CHI with persistent hypoglycemia while on standard of care treatment (SoC). HM15136 will be administered once weekly in multiple doses to subjects in multiple age including pediatric to find appropriate exposure-response data.
Conditions
- Congenital Hyperinsulinism
Interventions
HM15136Drug
Low dose of HM15136/ High dose of HM15136, SC injection, weekly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of incidence of AEs, TEAE, SAE as assessed by CTCAE v5.0Time frame: after multiple subcutaneous (SC) doses of 8 weeks
- Number of incidence of clinical laboratory abnormalitiesTime frame: after multiple subcutaneous (SC) doses of 8 weeks
- Maximum Serum Concentration [Cmax]Time frame: after multiple subcutaneous (SC) doses of 8 weeks
- Time to reach CmaxTime frame: after multiple subcutaneous (SC) doses of 8 weeks
Locations
7 sites in 5 countries. Site status is shown where the registry gives one.
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Otto-von-Guericke-Universitaet Magdeburg
Magdeburg, Germany
Hadassah Medical Center (HMC)
Jerusalem, Israel
Pusan National University Yangsan Hospital
Pusan, South Korea
Asan Medical Center
Seoul, South Korea
Great Ormond Street Hospital (GOSH) for Children NHS Foundation Trust
London, United Kingdom
Central Manchester University Hospitals NHS Foundation Trust - Royal Manchester Children's Hospital - Centre for Paediatrics and Child Health
Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.